You just read:

BioArctic: Alzheimer's Clinical Trials Consortium and Eisai Announce BAN2401 to be Evaluated in Clinical Study for Prevention of Alzheimer's Disease

News provided by

BioArctic

10 May, 2019, 08:54 BST